Verrica Pharmaceuticals VRCA
NASDAQ VRCA
$4.67 +0.21 (+4.77%)
As of: Sep 30, 2026 · 9:45 AM EDT

Verrica Pharmaceuticals (VRCA) Debt Ratio (2020 - 2025)

Updated

Verrica Pharmaceuticals' Debt Ratio was 0.30 in Q3 2025, down 6.0% from the prior quarter.

Analysis

Verrica Pharmaceuticals (VRCA) Debt Ratio (2020 - 2025) Analysis & Trends

For FY2024, Debt Ratio at Verrica Pharmaceuticals came in at 0.24.

  • In earlier years, Debt Ratio was 0.52 in FY2021 (-45.4%) and 0.95 in FY2020.
  • Quarterly Debt Ratio has moved between 0.24 (Q4 2024) and 0.95 (Q4 2020) over five years.
  • Per Business Quant data, VRCA's Debt Ratio in the three quarters before Q3 2025 was 0.32 (Q2 2025), 0.30 (Q1 2025) and 0.24 (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 0.24
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 0.52
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 0.42
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 0.31
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 0.00
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 0.60
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 0.53
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Verrica Pharmaceuticals 79.02 Mn -4.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 0.30
Jun 30, 2025 0.32
Mar 31, 2025 0.30
Dec 31, 2024 0.24
Jun 30, 2022 0.67
Mar 31, 2022 0.59
Dec 31, 2021 0.52
Sep 30, 2021 0.47
Jun 30, 2021 0.41
Mar 31, 2021 0.75
Dec 31, 2020 0.95
Sep 30, 2020 0.88
Jun 30, 2020 0.40
API Access

Verrica Pharmaceuticals Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=VRCA&period=max&api_key=YOUR_API_KEY